Features  |   September 2017
American Society of Addiction Medicine’s Drug Testing Guidelines: Clinical Congratulations, Questions and Concerns
Author Affiliations
  • Christopher Gharibo, M.D.
    Committee on Pain Medicine
Article Information
Quality Improvement / Features
Features   |   September 2017
American Society of Addiction Medicine’s Drug Testing Guidelines: Clinical Congratulations, Questions and Concerns
ASA Monitor 09 2017, Vol.81, 16-19.
ASA Monitor 09 2017, Vol.81, 16-19.
The American Society of Addiction Medicine (ASAM) has recently published “Appropriate Use of Drug Testing in Clinical Addiction Medicine” (www.asam.org/quality-practice/guidelines-and-consensus-documents/drug-testing) in an effort to provide guidance in the “identification, diagnosis, treatment, and promotion of recovery for patients with or who are at risk for addiction.”1  The guidance fills an important gap in that there are currently no universal standard drug tests for these purposes and, indeed, evidence is limited as to whether drug testing in addiction treatment improves outcomes and if there are ways to modify drug testing to better improve outcomes.
Considering the price for urine drug testing, particularly quantitative testing, it seems that careful consideration is prudent before adding expensive assays of unproven value.
First Page Preview
First page PDF preview
First page PDF preview ×
View Large
0 Comments
Submit a Comment
Submit A Comment

Contributors must reveal any conflict of interest. Comments are moderated.

Name
Affiliation & Institution
I have a potential conflict of interest
Comment Title
Comment


This feature is available to Subscribers Only
ASA Member Login or Create an Account ×